Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
03-Oct-2025 | 456 | 456 | 443.6 | 446.2 | 5,952 | 5,98,17,448.15 | 85,654 |
06-Oct-2025 | 445.05 | 450.9 | 438.2 | 441.3 | 7,419 | 8,73,12,288 | 1,28,252 |
07-Oct-2025 | 443 | 444.45 | 437 | 439.95 | 4,243 | 6,66,27,419.05 | 98,559 |
08-Oct-2025 | 440.95 | 446.4 | 438.05 | 440.5 | 4,402 | 6,10,29,066.25 | 77,366 |
09-Oct-2025 | 439.05 | 449 | 439 | 445.5 | 8,871 | 6,89,01,011.5 | 84,778 |
10-Oct-2025 | 446.4 | 456 | 443 | 446.15 | 9,022 | 7,94,37,636.75 | 99,169 |
13-Oct-2025 | 446.15 | 465.95 | 443.8 | 462.3 | 9,057 | 12,20,99,410.45 | 94,454 |
14-Oct-2025 | 465 | 465 | 452.2 | 459.55 | 6,172 | 7,62,98,880.85 | 88,242 |
15-Oct-2025 | 464.8 | 466 | 457.3 | 463.45 | 4,724 | 5,42,36,700.05 | 61,498 |
16-Oct-2025 | 460 | 465 | 459.3 | 462.4 | 3,559 | 3,62,49,374.45 | 43,886 |
17-Oct-2025 | 462.4 | 464.5 | 457.85 | 461.75 | 3,027 | 3,75,82,725.9 | 47,130 |
20-Oct-2025 | 464.1 | 469.9 | 461 | 466.85 | 3,085 | 4,27,53,433.4 | 45,456 |
21-Oct-2025 | 472 | 472 | 468.95 | 470.35 | 1,269 | 1,25,01,412.75 | 18,634 |
23-Oct-2025 | 472.1 | 473.45 | 461 | 463.05 | 3,244 | 3,80,64,543.9 | 51,446 |
24-Oct-2025 | 461.05 | 466 | 456.05 | 460.55 | 5,317 | 3,55,49,540.95 | 36,356 |
27-Oct-2025 | 460 | 471.05 | 457.5 | 465.9 | 2,388 | 3,49,39,848 | 46,626 |
28-Oct-2025 | 465 | 466.85 | 453.35 | 457.2 | 3,825 | 4,61,88,054.25 | 59,362 |
29-Oct-2025 | 457.2 | 471.5 | 452.3 | 467 | 3,164 | 4,65,56,950.95 | 33,210 |
30-Oct-2025 | 471 | 471 | 462.5 | 466.9 | 2,438 | 3,42,44,386.65 | 41,596 |
31-Oct-2025 | 468.9 | 468.9 | 459 | 460.75 | 2,924 | 2,46,30,213.2 | 32,163 |
The organisation is the largest CDMO serving the Indian pharmaceutical industry, with a proven track record and a broad clientele.
The IPO comprised a fresh issue of shares worth ₹680 crore and an offer-for-sale (OFS) of 1.73 crore shares, aggregating ₹1,177 crore.
The IPO consists of a fresh issue of ₹680 crore and an offer for sale (OFS) of up to 1.73 crore shares at a face value of ₹2 each.
On Monday, the business said that it had received ₹829 crore from anchor investors ahead of the public share sale subscription period.
The IPO includes a new issue of 1 Crore shares worth ₹680.00 Crore and an offer for sale of 1.73 Crore shares worth ₹1,176.74 Crore.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
